Novel mechanical mechanism of metastatic cancer cells in substrates of different stiffness revealed

October 16, 2020

During metastasis, cancer cells actively interact with microenvironments of new tissues. How metastatic cancer cells respond to new environments in the secondary tissues is a crucial question in cancer research but still remains elusive. Recently, researchers from the Hong Kong University of Science and Technology (HKUST), along with their international collaborators, discovered a novel mechanical mechanism of metastatic cancer cells in substrates of different stiffness, which could contribute to developing diagnostic tools for metastatic cancer cells and cancer therapeutics.

This study was published in the Journal of Physical Chemistry Letters on Sept 18, 2020.

In the study, the team of researchers, led by Prof. Hyokeun Park, assistant professor at the Department of Physics and Division of Life Science, HKUST, mimicked mechanical stiffness of diverse tissues from soft brain to bone using polyacrylamide (PAA) substrates and measured the mechanical responses of single metastatic breast cancer cells (MDA-MB-231 cells) against different stiffness, using advanced imaging techniques and the state-of-the-art magnetic tweezers which Prof. Park's group built in HKUST.

Using single-molecule tension sensors, they found that metastatic breast cancer cells change their tension in focal adhesions against the stiffness to adapt new environments whereas normal breast cells (MCF-10A cells) keep the similar tension regardless of stiffness. They also measured the viscoelasticity of single metastatic breast cancer cells using magnetic tweezers and found that metastatic cancer cells become more elastic on stiffer substrates while the viscoelasticity of normal cells remain similar.

These results show that metastatic breast cancer cells have stronger capacity to adapt to the mechanical environments of diverse tissues.

"How do metastatic breast cancer cells migrate and proliferate the secondary tissues of different stiffness from soft to hard tissue interface like brain to bone is a crucial question in cancer research," said Prof. Park. "Our work addressed how metastatic breast cancer cells proliferate the substrate of varying stiffness from 1kPa (similar to brain) to 50GPa(similar to bone), and we discovered that metastatic cancer cells change their viscoelasticity depending on physical environment to adapt their new physical environment and survive their new environment. This is one of big achievements in cancer physics and mechanobiology. The findings will contribute to developing diagnostic tools for metastatic cancer cells and, eventually, treatment of cancer."

This work was done in collaboration with Prof. Ching-Hwa Kiang at Rice University, Professor Jun Chu at Shenzhen Institutes of Advanced Technology and Prof. Ophelia Tsui in Department of Physics of HKUST.

The team is planning to develop a cancer diagnostic kit making use of the mechanism to measure tension of living potential cancer cells at different stiffness, which will be much simpler and more user-friendly than the existing diagnosis tools for metastatic cancer cells. Such mechanism could also be used to develop a drug-screening test for metastatic cancer to see how metastatic cancer cells' focal adhesion and viscoelasticity respond to different drugs and find the most effective drug for them.
-end-


Hong Kong University of Science and Technology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.